BLUE BELL, Pa.--(BUSINESS WIRE)--Feb. 7, 2006--Locus Pharmaceuticals, Inc., a computationally-based drug design and development company, announced today the continuation of its multi-stage research collaboration with Dow AgroSciences LLC, a subsidiary of The Dow Chemical Company (NYSE:DOW), focused on agrochemicals and biotechnology innovation. The collaboration involves the application of Locus’ proprietary computational technologies to design and develop novel small molecules to treat fungal targets identified by Dow AgroSciences. Financial and other terms of the agreement have not been disclosed. However, if the collaboration is successful, Locus will realize certain milestones and royalties and will have an exclusive option to human therapeutic applications.
